CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

Desk› Healthcare› Concord Drugs Ltd

Concord Drugs Ltd

BSE 538965 CONCORD INE858L01010

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

6 filings · 2 material · busiest 2026-08-10

What it files

Newspaper Publication1 Board Outcome1 Results1 Board Meeting1 Compliance Certificate1 Trading Window1

Filings

6 in the window

12 August 2026

Newspaper Publication

Newspaper Publication

Copy of News-paper publications for quarterly results ended 30th June 2026.

Company Update / Newspaper Publication View filing →
10 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board meeting

Board Meeting / Outcome of Board Meeting View filing →
10 August 2026

Results

Financial Results For Quarter Ended 30 June 2026

Board of Directors have approved stand alone and consolidated Un-audited financial results for 30th June 2026

Result / Financial Results View filing →
3 August 2026

Board Meeting

Board Meeting Intimation for Quarterly Results

Concord Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Quarterly Results

Board Meeting / Board Meeting View filing →
13 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74(5) of SEBI (DP) Regulations

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
25 June 2026

Trading Window

Closure of Trading Window

Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →